1
Slow increment PUVA therapy was able to induce good tolerance to sun exposure.
2
One trial of PUVA therapy led to an urticarial reaction of the entire body.
3
Acitretin and bath PUVA may be safely combined for the treatment of severe psoriasis.
4
Gen. Hospital were developing the PUVA program to treat psoriasis.
5
The mean total dose of PUVA for complete clearing was less for early MF.
6
Two 54-year-old otherwise healthy female patients received a course of PUVA after trying other alternatives.
7
The advantage of PUVA therapy is a more long lasting protection allowing weekly maintenance sessions.
8
PUVA is the only treatment that decreases epidermal LCs.
9
Patients were most satisfied with methotrexate and PUVA.
10
If antihistamines are ineffective, PUVA therapy is indicated.
11
Interferon plus PUVA appears to be a highly effective regimen for the treatment of patients with CTCL.
12
Interferon plus PUVA appear to be highly effective regimens for the treatment of patients with cutaneous T-cell lymphomas.
13
For all these features, 3b seemed to be a new promising potential drug for PUVA therapy and photopheresis.
14
Except for PUVA and ciclosporin, long-term safety data from formal postmarketing studies are also largely lacking conventional treatment options.
15
Patients in early stages of the disease remained clear for up to 68 months after the first course of PUVA.
16
Cyclosporin A may also prove useful alone in very low doses or in combination therapy, as with UVB or PUVA.